Clinical Trials · NCT03486392
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Janssen Research & Development, LLC
- Enrollment
- 474
- Start date
- Mar 2018
- Locations
- 51 sites, 6 countries
- Primary endpoint
- Percent Change From Baseline in Body Weight at Week 26